Our BIOXIGEN® air purifiers have been proven efficient against coronavirus

In Non classé
In a difficult sanitary context, patients with fragile immunity must be protected as much as possible.

This has been demonstrated in a lab report from Pavia, Italy, that has defined Bioxigen®:

Efficient against all enveloped viruses (including coronaviruses such as SARS-Cov-2) « .

Imagine an infected person coughing in a closed room: a cloud of aerosols filled with the virus spreads and becomes the airborne transmission factor to healthy people entering the room: it could be a shop, a dental office, the reception of your offices, home …

BIOXIGEN® disinfection technology has been tested against COVID-19.

How did the test go? The independent Italian laboratory, LabAnalysis, sprayed the virus in a closed room. Samples from the infected area were taken at several intervals. The results revealed that after 60 minutes of exposure of the BIOXIGEN® system through the Maia device – the virus was inoculated to over 95%

Protecting the vulnerable patients

Virus destruction in less than 5 minutes

BIOXIGEN® integrated into the ROOM DOPAIR® and DOPAIR® systems

This new report reinforces the evidence of the effectiveness of Room Dopair® / Dopair® systems, mobile decontamination units for high-risk areas.

Integrated in an absolute filtration system and with the necessary air circulation rate, the Bioxigen® system becomes more than 99.99% effective against coronaviruses, in record time.

Aerosols containment in less than 5 minutes

In hospitals, where the control of airborne transmission is a major issue, our Room Dopair® and Dopair® solutions ensure the destruction of coronaviruses and other pathogens in less than 5 minutes. Compliant with French standard NF S 90351 related to air hygiene in high-risk and controlled environments, they have been tested 99.94% effective against COVID-19.

Whether in a high-risk environment, or in any closed indoor space, our different solutions make a difference in the daily life of many people, in particular those vulnerable to the disease:

  • People aged 65 and over
  • People with chronic pathologies
  • Patients with cardiovascular history
  • Patients with congenital or acquired immunosuppression
  • Pregnant women and children
  • People with asthma, pulmonary fibrosis or allergies

Click here to view our test reports on COVID-19 and other airborne infections